Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Key Goals Behind Top Investor’s Moves

(Image via HEXO Corp.) At Stockhouse, investor focus is on companies whose valuations seem a little more firmly rooted in down on planet Earth. When it comes to the most popular stocks over the previous week, three names are dominating, especially where health care ...
Stockhouse Editorial | September 22, 2021 |

Buzz on the Bullboards: Hot Summer Stocks Ahead of the Autumn Rush

(Image via Bombardier Inc.) Investors, our audience, and even some executives regularly visit this site to see how their companies and investing strategies are faring in the community. This week, our highlights go to the newer (and returning) companies that have...
Stockhouse Editorial | September 1, 2021 |

NervGen Pharma: A “Blockbuster Drug” in the Making?

It has the potential to be one of the most disruptive pharmaceutical drug therapies of the modern era, especially for treating Alzheimer’s disease. And that gives it considerable “blockbuster drug” potential – a tantalising opportunity tha...
Marc Davis | June 25, 2021 |

Biopharma Co. Makes Major Headway Toward Clinical Trials for Treatment of Stroke

(CLICK IMAGE TO PLAY VIDEO) Finding an effective method of preventing the possibility of stroke is something that medical science has grappled with for decades. Now, a Vancouver-based clinical stage biopharmaceutical development company looks to be making significa...
Dave Jackson | June 16, 2021 |

Exploring Four High-Grade Gold Projects in a “Bonanza” District

The circus of despair that has been 2020 was – among other things – a transformative time for the vast majority of industries, businesses and people around the world. From the utter collapse of global stock markets in mid-March to a soaring gold price that peaked in early Aug...
Oliver Gray | January 7, 2021 |

Flying Under the Radar with a Possible COVID-19 Treatment

Investors would think a pharmaceutical company heading into Phase 2b/3 human trials for treating the third most malignant disease after lung cancer and pancreatic cancer would draw eyes from major players. If that same company announced it was embarking on Phase2b/3 human tri...
Stockhouse Editorial | September 8, 2020 |

New Listing & Already Profitable? How This Gaming Company is Capturing the Market

(Image via PopReach) The video game market has gone from an entertainment afterthought in the 2000’s to the largest media market in the world. But what’s the best way for investors to play in the space? Many instinctively look to th...
Stockhouse Editorial | July 8, 2020 |

Why This Small-Cap Miner Could Be a 'Once-in-a-Generation Wealth Builder'

I had been familiar with the story and potential of uber micro-cap (a valuation of little more than C$3 million or so for a LONG time!) Omineca Mining and Metals Ltd.'s (OMM:TSX.V; OMMSF:OTCMKTS) for years. But as gold was beginning to percolate and other necessa...
Streetwise Reports | June 24, 2020 |

Westwater Shares Charge Higher after Demonstrating Simulated Full-Scale Battery Graphite Processing

Shares of Westwater Resources traded higher on greater than 100-times average daily volume after the company reported that positive independent test results on ULTRA-PMG™ demonstrated successful simulated full-scale processing of battery graphite. Energy materials ...
Streetwise Reports | June 3, 2020 |

Small-Cap Pharma Fast-Tracking Repurposed Drug for Covid-19

Algernon Pharmaceuticals is quickly moving ahead with a multinational Phase 2b/3 trial for Ifenprodil. Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW:FSE) , a Canada-based clinical stage drug development company that focuses on drug repurposing, believes ...
Streetwise Reports | May 28, 2020 |
1 2